Thermo Fisher Scientific Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Apr 2017 | $15.19B | $21.80B | $713.3M |
| Jul 2017 | $15.26B | $22.39B | $611.0M |
| Sep 2017 | $19.23B | $24.70B | $741.1M |
| Dec 2017 | $18.87B | $25.41B | $1.34B |
| Jan 2018 | $18.87B | — | — |
| Mar 2018 | $18.12B | $26.12B | $950.0M |
| Jun 2018 | $17.71B | $26.45B | $937.0M |
| Sep 2018 | $17.76B | $26.89B | $1.10B |
| Dec 2018 | $17.72B | $27.59B | $2.10B |
| Mar 2019 | $16.81B | $27.69B | $1.11B |
| Jun 2019 | $16.66B | $28.73B | $2.29B |
| Sep 2019 | $16.39B | $29.36B | $1.27B |
| Dec 2019 | $17.08B | $29.68B | $2.40B |
| Mar 2020 | $19.23B | $28.56B | $2.98B |
| Jun 2020 | $20.64B | $29.88B | $5.82B |
| Sep 2020 | $21.09B | $31.82B | $7.54B |
| Dec 2020 | $19.11B | $34.51B | $10.33B |
| Apr 2021 | $18.64B | $35.06B | $5.58B |
| Jul 2021 | $18.77B | $36.85B | $7.02B |
| Oct 2021 | $21.60B | $38.71B | $12.03B |
| Dec 2021 | $34.67B | $40.79B | $4.48B |
| Apr 2022 | $33.06B | $40.96B | $2.75B |
| Jul 2022 | $30.06B | $42.29B | $1.89B |
| Oct 2022 | $28.94B | $43.55B | $2.92B |
| Dec 2022 | $34.28B | $43.98B | $8.52B |
| Apr 2023 | $35.05B | $42.26B | $3.48B |
| Jul 2023 | $33.81B | $43.75B | $3.13B |
| Sep 2023 | $35.08B | $45.33B | $6.15B |
| Dec 2023 | $34.73B | $46.74B | $8.08B |
| Mar 2024 | $35.39B | $45.52B | $5.50B |
| Jun 2024 | $35.20B | $47.43B | $7.07B |
| Sep 2024 | $35.11B | $48.99B | $4.65B |
| Dec 2024 | $31.07B | $49.58B | $4.01B |
| Mar 2025 | $33.99B | $49.39B | $4.13B |
| Jun 2025 | $35.03B | $50.51B | $4.58B |
| Sep 2025 | $35.48B | $51.02B | $1.98B |
| Dec 2025 | $39.17B | $53.41B | $9.85B |
| Mar 2026 | $42.95B | $51.93B | $3.25B |
| Jun 2026 | $42.28B | $52.68B | $4.06B |